TaraL.DallMDFNLA

PubMed

• 7 citations
  Comparison of cardiometabolic risk biomarkers from a national clinical laboratory with the US adult population
  Elliott Wolin, Justin White, James V. Pottala, Maciek Sasinowski, Tara Dall, Thomas D. Dayspring, Joseph P. McConnell, Daniel M. Hoefner, Stephen A. Varvel, Dawn L. Th...> ;Journal of Clinical Lipidology. 2015 Nov 1
• 16 citations
  Discordance between apolipoprotein B and low-density lipoprotein particle number is associated with insulin resistance in clinical practice
  Stephen A. Varvel, Thomas D. Dayspring, Yvette Edmonds, Dawn L. Thiselton, Leila Ghaedi, Szilard Voros, Joseph P. McConnell, Maciek Sasinowski, Tara Dall, G. Russell W...> ;Journal of Clinical Lipidology. 2015 Mar 1
• 22 citations
  Serum α-hydroxybutyrate (α-HB) predicts elevated 1 h glucose levels and early-phase β-cell dysfunction during OGTT
  Stephen A. Varvel, James V. Pottala, Dawn L. Thiselton, Rebecca E. Caffrey, Tara Dall, Maciek Sasinowski, Joseph P. McConnell, G. Russell Warnick, Szilard Voros, Timot...> ;BMJ Open Diabetes Research & Care. 2014 Sep 1
• 10 citations
  Comprehensive biomarker testing of glycemia, insulin resistance, and beta cell function has greater sensitivity to detect diabetes risk than fasting glucose and HbA1c ...
  Stephen A. Varvel, Szilard Voros, Dawn L. Thiselton, James V. Pottala, Tara Dall, G. Russell Warnick, Joseph P. McConnell, Leila Ghaedi, Maciek Sasinowski, Timothy E. ...> ;Journal of Cardiovascular Translational Research. 2014 Jul 29
• 1 citations
  Targeting insulin resistance: the ongoing paradigm shift in diabetes prevention.
  Tara Dall, Dawn L. Thiselton, and Stephen Varvel> ;The American Journal of Managed Care. 2013 Apr 11
• 16 citations
  Opportunities for using lipoprotein subclass profile by nuclear magnetic resonance spectroscopy in assessing insulin resistance and diabetes prediction.
  Alexis C. Frazier-Wood, W. Timothy Garvey, Tara Dall, Robert Honigberg, Ray Pourfarzib> ;Metabolic Syndrome and Related Disorders. 2012 Jul 19
• 12 citations
  Effects of an office-based carotid ultrasound screening intervention.
  Heather M. Johnson, Terry L. Turke, Mark Grossklaus, Tara Dall, Sanford Carimi, Laura M. Koenig, Susan E. Aeschlimann, Claudia E. Korcarz, James H. Stein> ;Journal of the American Society of Echocardiography. 2011 Jul 1
• 1 citations
  Addressing lipid treatment targets beyond cholesterol: a role for prescription omega-3 fatty acid therapy.
  Tara L. Dall, Harold Bays> ;Southern Medical Journal. 2009 Apr 1
• Join now to see all

Journal Articles

• Comparison of cardiometabolic risk biomarkers from a national clinical laboratory with the US adult population  
  Elliott Wolin, PhD, Justin White, MS, James V. Pottala, PhD, Maciek Sasinowski, PhD, MD, Tara Dall, MD, Thomas D. Dayspring, MD, Joseph P. McConnell, PhD, Daniel M. Ho..., Journal of Clinical Lipidology, 1/1/2015
• Comprehensive Biomarker Testing of Glycemia, Insulin Resistance, and Beta Cell Function Has Greater Sensitivity to Detect Diabetes Risk Than Fasting Glucose and HbA1c ...  
  S Varvel, S Voros, D Thiselton, J Pottala, T Dall, G Warnick, J McConnell, L Ghaedi , M Sasinowski, T Graham, J Cardiovasc Transl Res, 1/1/2014
• Discordance between apolipoprotein B and low-density lipoprotein particle number is associated with insulin resistance in clinical practice  
  Stephen A. Varvel, PhD, Thomas D. Dayspring, MD, Yvette Edmonds, PhD, Dawn L. Thiselton, PhD, Leila Ghaedi, PhD, Szilard Voros, MD, Joseph P. McConnell, PhD, Maciek Sa..., J Clin Lipidol, 1/1/2014
• Serum alpha-hydroxybutyrate (alpha-HB) predicts elevated 1-hour glucose levels and early-phase beta-cell dysfunction during OGTT  
  Stephen A. Varvel, PhD; James V. Pottala, PhD; Dawn L. Thiselton, PhD; Rebecca Caffrey, PhD; Tara Dall, MD; Maciek Sasinowski, MD, PhD; Joseph P. McConnell, PhD1; G. R..., BMJ Open Diabetes Res Care, 1/1/2014
• Targeting insulin resistance: the ongoing paradigm shift in diabetes prevention  
  Dall T, Thiselton D, Varvel S, Am J Manag Care, 1/1/2013
• Opportunities for Using Lipoprotein Subclass Profile by Nuclear Magnetic Resonance Spectroscopy in Assessing Insulin Resistance and Diabetes Prediction  
  Alexis C. Frazier-Wood, Timothy W. Garvey, Dall, T, Honigberg, Ray Pourfarzib, Metab Syndr Relat Disord, 1/1/2012
• Effects of an Office-Based Carotid Ultrasound Screening Intervention  
  Johnson HM, Turke TL, Grossklaus M, Dall T, Carimi S, Koenig LM, Aeschlimann SE, Korcarz CE, Stein JH, J Am Soc Echocardiography, 1/6/2011
• Advanced Lipid Testing: Beyond LDL–P and Apo B  
  Dall TL, Lipid Spin, Summer, 1/1/2011
• Clinical Utility of Low-Density Lipoprotein Measurement in Management of Cardiovascular Disease: A Case Study  
  Dall, Tara, Pourfarzib, Ray, Research Reports in Clinical Cardiology, 1/1/2011
• Moving beyond LDL-C: incorporating lipoprotein particle numbers and geometric parameters to improve clinical outcomes  
  Dayspring, Tom. Dall, Tara. Abuhajir, Majed, Research Reports in Clinical Cardiology, 1/1/2010
• Addressing Lipid Treatment Targets Beyond Cholesterol: A role for Prescription Omega-3 Acid therapy  
  Dall, Tara. Bays, Harold, Southern Medical Journal, 1/1/2009
• Featured cover article: Vitamin D Merging Research into Clinical Lipid Practice  
  Dall TL, Lipid Spin, Summer, 1/1/2008
• Polycystic Ovarian Syndrome, insulin resistance, and lipids  
  Dall TL, Lipid Spin, Winter, 1/1/2007
• Join now to see all

Abstracts/Posters

• Discordance between apoB and LDL-P in clinical practice is associated with insulin resistance.
  Stephen A. Varvel, PhD; Thomas D. Dayspring, MD; Tara Dall, MD; Dawn L. Thiselton, PhD; Yvette M. Edmonds, PhD; Joseph P. McConnell, PhD; G. Russell Warnick, MS, MBA, National Lipid Association Annual Scientific sessions, Las Vegas, NV, 1/31/2013
• Determination of Desmosterol, Campesterol, Cholestanol and b-Sitosterol in plasma utilizing LC-MS/MS in Clinical Diagnostics
  James Bruton, Joseph McConnell, Dan Hoefner, Tara Dall, Thomas Dayspring, American Society for Mass Spectrometry, 1/8/2013
• Heterogeneity of Low-Density Lipoprotein Particle Number (LDL-P) at Normal Concentrations of Lipoprotein (a) in Hyperlipidemia Patients
  Hector Malave, MD, Richard Wright, MD, Tara Dall, MD, Barney B. Beaver, DO, Ray Pourfarzib, PhD, National Lipid Association Annual Scientific sessions, Scottsdale, AZ, 1/31/2012
• Elevated Low-Density Lipoprotein Particle Number in Dyslipidemic Patients with Diabetes Having Achieved ATP III Treatment Goals.
  Dall TL, Ballantyne CM, Pourfarzib R, Hailpern SM, American Diabetes Association’s 70th Scientific Sessions, 1/27/2010
• High- and Low-Density Lipoprotein Particle Number in Dyslipidemic Persons With Type 2 Diabetes Having Achieved ATP III Treatment Goals.
  Dall TL, Pourfarzib R, Hailpern SM, 6th International Atherosclerosis Society, 1/19/2010
• Low-Density Lipoprotein Particle Number is Heterogeneous Among Persons With and Without Type 2 Diabetes and LDL Cholesterol <100 mg/dL.
  Dall TL, Pourfarzib R, National Lipid Association Annual Scientific Session, 1/13/2010
• Detection of subclinical atherosclerosis by office-based carotid ultrasound increases prescription of preventive therapies.
  Johnson HM, Turke TL, Grossklaus M, Dall T, Carimi S, Koenig LM, Aeschlimann SE, Korcarz CE, Stein JH, Journal of the American College of Cardiology; 59th Annual Scientific Sessions of the American College of Cardiology, Atlanta, GA, 1/1/2010
• Effects of office-based carotid ultrasound on health-related behaviors and perceptions of cardiovascular disease risk in patients.
  Johnson HM, Turke TL, Grossklaus M, Dall T, Carimi S, Koenig LM, Aeschlimann SE, Korcarz CE, Stein JH, Journal of the American College of Cardiology; 59th Annual Scientific Sessions of the American College of Cardiology, Atlanta, GA, 1/1/2010
• Effect of Metformin on Lipoprotein Particle Concentration in Pediatric Patients with Obesity and Dyslipidemia
  Dall TL, Vasudevan MM, Ballantyne CM, Pourfarzib R, Diabetes; American Diabetes Association, 1/1/2009
• Join now to see all

Lectures

• Heart Disease and Stroke Prevention: Information that may save your life 
  George Washington University, Washington, DC - 1/19/2016
• Early detection for heart disease and diabetes through the use of biomarker testing. 
  1/3/2016
• Biomarkers role in personalized medicine. 
  Baton Rouge, LA - 1/27/2015
• Prevention of Heart Attack and Strokes 
  John Hopkins Hospital's Turner Auditorium - 1/24/2015
• Preventive Cardiology lecture series 
  1/22/2015
• Biomarker testing: clinical advances. 
  Fairfax Inova Hospital, Fairfax, VA - 1/18/2015
• Optimizing lifestyle Intervention Based on Lipid Analysis and Biomarkers 
  Denver, CO - 1/11/2015
• Using biomarkers to Assess risk and guide treatment in patients affected by Obesity and Patients with obesity-related metabolic disease. 
  Denver, CO - 1/11/2015
• NMR lipoprofile: Science and clinical application. 
  Guatamala City, Guatemala - 1/10/2015
• Preventive Cardiology biomarker lecture series 
  1/2/2015
• New concepts in Lipidology 
  Sacramento, CA - 1/27/2014
• Biomarkers: personalized medicine, the future of medicine. Clinical applications 
  Hampton Roads, VA - 1/25/2014
• Polycystic Ovarian Syndrome: role of biomarkers in treatment and management. 
  Eastern VA Medical School Norfolk, VA - 1/18/2014
• Complex lipid management: lowering triglycerides and raising HDL: how to do it and is it of value. 
  Hilton, Austin, TX - 1/12/2014
• The truth inside you: why traditional testing fails to prevent heart disease. 
  Hilton, Austin, TX - 1/12/2014
• Using Biomarkers to Age Well 
  Las Vegas, NV - 1/10/2014
• Solving the Heart Disease puzzle: Empowering Patients lowering Costs 
  Richmond, VA - 1/10/2014
• Biomarkers: Understanding the Science, Real life application (CME) 
  Sioux Falls Convention Center, Sioux Falls, SD - 1/7/2014
• Women and Heart Disease, Advanced Lipid Testing: Case based application. 
  Miami, FL - 1/6/2014
• Biomarkers update 
  Ashville, NC - 1/5/2014
• Advanced Biomarker testing 
  Falls Church, VA - 1/5/2014
• Addressing the diabetes epidemic: Empowering patients lowering cost 
  Capital One Center, Richmond, VA - 1/27/2013
• Happy, Healthy & Whole 
  Richmond, VA - 1/27/2013
• Tackling Runaway Health Care Costs 
  1/26/2013
• Advanced Biomarker Testing: Case based Approach 
  Chicago, IL;2013; Richmond, VA, 2013 - 1/24/2013
• Join now to see all

Other

• Learn important information about high cholesterol and diabetes in children. 
  Dall TL, WTVR, Virginia This Morning
  1/16/2015
• Insulin resistance: Belly fat 
  Dall TL, WTVR, Virginia This Morning
  1/1/2015
• Managing statin Tolerance and Adherence 
  Dall TL, Heart.org
  1/31/2012
• Personalizing Lipid Management: Addressing Statin Intolerance and Adherence in Clinical Practice 
  Tara L. Dall, MD; Peter Howard Jones, MD, Medscape, CME
  1/26/2012
• Why is Targeting LDL-C Not Enough? The Data On Low HDL-C and Residual CV Risk 
  Tara Dall, MD; James Underberg, MD, Medscape, CME
  1/17/2012
• Polypharmacy and Statin selection: Reducing the potential for drug drug interactions. 
  Dall TL, CME theheart.org and Medscape.com
  1/1/2012
• Polypharmacy and Statin Selection: Individualizing Lipid-lowering Therapy to Reduce the Potential for Drug-drug Interactions. 
  Dall TL, heart.org video
  1/19/2011
• Polypharmacy and Statin Selection: Reducing the Potential for Drug-Drug Interactions. Online Publication 
  JoAnne M. Foody, MD; Tara Dall, MD
  http://www.medscape.org/viewarticle/752891Cached
  1/7/2011
• Lipid Luminations: LDL particle testing. 
  Dall TL, REACH MD Satellite radio, host Alan Brown, MD
  1/18/2010
• A Patient With Coronary Artery Disease and Low High-Density Lipoprotein. 
  Dall, Tara, Lipidsonline.org, CME activity
  1/1/2010
• Lifesaving Test (Special Report) 
  Dall TL, WTMJ –TV NBC Affiliate
  1/28/2009
• High triglycerides and use of Omega 3 fatty acids 
  Dall TL, CNN radio Health Watch, host Jackie Howard
  1/1/2008
• Cholesterol education focus on children. 
  Dall TL, FOX news Medical Minute
  Milwaukee, WI - 1/1/2008
• interview- High Triglycerides 
  Dall TL, Radio Health Journal
  1/1/2008
• Guest, Lipid Luminations: PCOS and cardiovascular risk. 
  Dall TL, REACH MD Satellite radio, host Larry Kaskal
  1/1/2008
• Featured story on early detection of heart disease with advanced lipid testing. 
  Dall TL, WISN-TV
  1/28/2007
• Guest on Lipid Luminations 
  Dall TL, REACH MD Satellite Radio
  1/8/2007
• Metabolic syndrome: to be, or not to be. 
  Dall, Tara, DALM conference coverage Online Medscape
  1/1/2007
• Featured interview “Go Red Check up” 
  Dall TL, Milwaukee Home Magazine
  1/1/2007
• Mechanism of action of Triglycerides 
  Dall TL, Web MD
  http://www.medscape.com/infosite/lovaza
  1/1/2007
• Cholesterol & Lifestyle Center Pedometer story 
  Dall TL, WISN-TV Special report
  1/1/2007
• PCOS and heart disease risk. 
  Dall TL, Fox News Healthy Living Segment
  Milwaukee, WI - 1/13/2006
• Small LDL particles Bullies looking for trouble. Interview. 
  Dall TL, Track your Plaque
  http://www.trackyourplaque.com/
  1/1/2006
• Women and Heart Disease 
  Dall TL, Fox News Medical Minute
  Milwaukee, WI - 1/18/2005
• Join now to see all